Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Jubilant Pharmova Ltd Q1FY22 consolidated net profit drops QoQ to Rs. 160.49 crores

Posted On: 2021-07-23 12:00:05 (Time Zone: UTC)


JUBILANT Pharmova LIMITED has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.1638.54 crores during the period ended June 30, 2021 as compared to Rs.1586.47 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.160.49 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.213.65 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.10.09 for the period ended June 30, 2021 as compared to Rs.13.43 for the period ended March 31, 2021.

FinancialsQ1 FY2021-22Q4 FY20-21% Change
Total Income₹ 1638.54 crs₹ 1586.47 crsUp Tick 3.28%
Net Profit₹ 160.49 crs₹ 213.65 crsDown Tick -24.88%
EPS₹ 10.09₹ 13.43Down Tick -24.87%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.1638.54 crores during the period ended June 30, 2021 as compared to Rs.1159.98 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.160.49 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.88.01 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.10.09 for the period ended June 30, 2021 as compared to Rs.5.53 for the period ended June 30, 2020.

FinancialsQ1 FY2021-22Q1 FY2020-21% Change
Total Income₹ 1638.54 crs₹ 1159.98 crsUp Tick 41.26%
Net Profit₹ 160.49 crs₹ 88.01 crsUp Tick 82.35%
EPS₹ 10.09₹ 5.53Up Tick 82.46%

Commenting on Company's performance, Mr. Shyam S Bhartia, Chairman and Mr. Hari S Bhartia, Co-Chairman & Managing Director, Jubilant Pharmova said: "During this quarter, in addition to YoY increase, we also reported sequential improvement in the Specialty Pharma segment with gradual recovery across radiopharmaceuticals, Radiopharmacy and Allergy business. In radiopharmaceuticals, we have enhanced efforts to promote existing products as well as expand our product pipeline with strategic partnerships. With a gradual recovery in nuclear medicine procedures, the turnaround plan of Radiopharmacy business is on track. CMO business continued to benefit from COVID related deals.

Contract Research and Development Services business witnessed strong YoY growth in revenues led by healthy demand from customers. We have doubled our chemistry research capacity and the facility is operational now. Despite COVID-19 related lockdowns, we have been able to ensure continuity in most of our manufacturing operations across all business segments while at the same time ensuring safety of our employees. I take this opportunity to thank all our employees who have worked tirelessly across all our plants and offices to ensure continuity in company's operations, while continuing to serve our global customers."

Shares of JUBILANT Pharmova LIMITED was last trading in BSE at Rs. 696.9 as compared to the previous close of Rs. 715.4. The total number of shares traded during the day was 56389 in over 3924 trades.

The stock hit an intraday high of Rs. 723 and intraday low of 692.15. The net turnover during the day was Rs. 40031423.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Biocon Biologics and Serum Institute Life Sciences announce Strategic Alliance

Shreyas Shipping & Logistics Ltd to acquire bulk carrier

Precision Camshafts Limited retrofits passenger AC bus into 100% Electric Bus

Mahindra and Mahindra restructures its Farm Equipment business in Turkey

Intellect bags a large multiple-year digital transformation destiny deal from Resurs Bank

Hero MotoCorp to increase prices of its Motorcycles and Scooters

Cosmo Films announces BOPP expansion and 1st interim dividend

Indiabulls Housing Finance Ltd opens FCCB issue

Frost Bank Selects Infosys as Strategic Partner to Launch New Mortgage Loan Product Offering

Cosara Diagnostics receives CDSCO license to manufacture SARAGENE® Dengue Test Kit

Kotak Mahindra Bank Partners Indian Institute of Science to set up the Kotak-IISc AI-ML Centre at IISc Campus, Bengaluru

Sirca Celebrates Jashn-e-Rang with Key Partners

Edelweiss AMC appoints Trideep Bhattacharya as CO-CIO Equities

Poonawalla Fincorp Limited announces resignation of MD

EKI Energy Services Ltd extends time line to acquire stake in SustainPlus Rise Pvt Ltd

TVS Motor Company forays into the personal e-mobility business with a majority stake in European e-bike brand EGO Movement

Cosmo Films Ltd to set up new production for BOPP films at Aurangabad

Kotak Mahindra Group Acquires Vehicle Financing Portfolio of Volkswagen Finance

HCL Technologies Celebrates One Year in Sri Lanka

Ace Men Engg Works Ltd announces resignation of MD

Balkrishna Industries Ltd commences trial production at Waluj

KPIT Technologies Ltd appoints Ms. Bhavna Doshi as additional director

Cosmo Films Ltd board declares 1st interim dividend of Rs. 25

Axtel Industries Ltd reappoints Shri Ajay Naishad Desai as Executive Director

Star Housing Finance Ltd board to consider preferential issue on Sep 21, 2021

Aptech Limited announced the launch of its EdTech initiative - christened it ProAlley.com

Saregama India Ltd board approves fund raising of Rs. 750 crore

Mahindra Lifespaces® appoints Jitesh Donga as Chief of Design

PG Electroplast Ltd arm applies for DPIIT under PLI for White Goods

Action Construction Equipment Ltd receives LoI for supply of cranes

BHEL commissions India's largest floating Solar PV plant

TVS Motor Company launches Naked Street Design 'TVS Raider' motorcycle globally for the Gen Z

CARE assigns rating to The Federal Bank Ltd's Basel III Tier 2 bonds

EaseMyTrip expands international presence to Philippines, Thailand, and the USA

ICRA-assigned Credit Rating for Rs. 103.02 crore Line of Credit of Shalby Limited

Dilip Buildcon Ltd receives LOA for new HAM project Bangalore-Chennai Expressway under Bharatmala worth Rs. 1060 Crores

Poonawalla Fincorp Limited appoints Mr. Sharad Pareek as Chief Risk Officer

Hero MotoCorp Ltd hands over 13 life-support ambulances to the Government of Uttarakhand

Fitch Revises Outlook on Shriram Transport Finance to Stable, Affirms at 'BB'

NCLT approves the scheme of amalgamation of Lincoln Parenteral Ltd and Lincoln Pharmaceuticals Ltd

Mahindra Finance announces entry into Vehicle Leasing and Subscription business under 'Quiklyz' brand

SC asks release of Rs. 357.79 Crores plus accrued interest to Manaj Tollway Private Limited

New Auto sector PLI to boost Electric Vehicles in India

Sunteck Realty plans JDA to develop 10 mn sq ft at Shahad

India Ratings assigns The Federal Bank's Additional Basel III Tier 2 Bonds 'IND AA'/Stable

Lupin Limited updates on lawsuits regarding Glumetza®

Syschem India Ltd redeems NCNCRPS and repays unsecured loan

Finolex Industries Ltd approves proposal for transfer of leasehold rights of MIDC land

Government's PLI policy for Drones to be a big boost for the sector - RattanIndia Enterprises

Dalmia Bharat Sugar and Industries Ltd launches Dalmia Utsav Honey


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020